Drug information for METAGLIP
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET; ORAL
2.5MG;250MG
Discontinued
GLIPIZIDE
;
METFORMIN HYDROCHLORIDE
metaglip
BRISTOL MYERS SQUIBB
21460
2011-02-04 Label
2011-02-03 Letter
2009-11-25 Letter
2009-09-18 Label
2008-08-26 Label
2008-08-20 Letter
2007-07-05 Letter
2007-06-27 Label
2003-04-30 Review
2002-10-21 Letter
2002-10-21 Label
TABLET; ORAL
2.5MG;500MG
Discontinued
GLIPIZIDE
;
METFORMIN HYDROCHLORIDE
metaglip
BRISTOL MYERS SQUIBB
"
TABLET; ORAL
5MG;500MG
Discontinued
GLIPIZIDE
;
METFORMIN HYDROCHLORIDE
metaglip
BRISTOL MYERS SQUIBB
"
Drug Adverse Effects information for METAGLIP
Role code
Indications
Reaction
# Reports
C
DIABETES MELLITUS
FATIGUE
1
C
DIABETES MELLITUS
HYPERLIPIDAEMIA
1
C
DIABETES MELLITUS
HYPERTENSION
1
C
PRODUCT USED FOR UNKNOWN INDICATION
ADVERSE EVENT
1
C
PRODUCT USED FOR UNKNOWN INDICATION
PRODUCT QUALITY ISSUE
1
Ads by Google